Michael G.

Michael G. is an accomplished regulatory strategist with extensive experience in the life sciences sector. Currently serving as Senior Director and Global Regulatory Lead at PepGen since November 2024, Michael has previously held key positions such as Head of Regulatory Affairs at Faeth Therapeutics and Founder & CEO of Lingua Franca Therapeutics. Michael's career includes significant roles in regulatory affairs at Kaleido Biosciences and its predecessor, Midori USA, where contributions included developing innovative regulatory strategies that accelerated product development. With a strong educational background, including a BS and M.Eng/MBA from Washington University in St. Louis and studies at Imperial College London, Michael combines technical expertise with entrepreneurial experience across various startups.